tiprankstipranks
US Nuclear Corp. (UCLE)
OTHER OTC:UCLE
US Market
Want to see UCLE full AI Analyst Report?

US Nuclear (UCLE) AI Stock Analysis

76 Followers

Top Page

UCLE

US Nuclear

(OTC:UCLE)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - Gpt-5.6Sol)
Rating:41Neutral
Price Target:
$0.03
▼(-13.33% Downside)
Action:Reiterated
Date:08/18/26
Overall score is held down primarily by weak financial performance (ongoing losses, negative free cash flow, and negative equity), despite some improvement in 2025. Technicals add further pressure with the stock trading below key moving averages, while valuation inputs are constrained by a negative P/E and отсутствing dividend yield data.
Positive Factors
Improved Product Economics
The recovery in gross margin indicates better product economics or cost control. If sustained, it could improve the company’s ability to convert relatively stable revenue into operating profit and support eventual progress toward breakeven.
Negative Factors
Persistent Unprofitability
The company has not demonstrated a durable path to profitability. Continued operating and net losses limit internally generated capital, make growth investments harder to fund, and leave performance dependent on a successful future revenue or margin recovery.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved Product Economics
The recovery in gross margin indicates better product economics or cost control. If sustained, it could improve the company’s ability to convert relatively stable revenue into operating profit and support eventual progress toward breakeven.
Read all positive factors

US Nuclear (UCLE) vs. SPDR S&P 500 ETF (SPY)

US Nuclear Business Overview & Revenue Model

Company Description
US Nuclear Corp. (UCLE) is a global entity dedicated to the engineering, production, and sale of advanced radiation detection and measurement technologies. The company conducts its operations through two primary divisions: Optron and Overhoff. Its...
How the Company Makes Money
U.S. Nuclear primarily makes money by selling radiation detection and monitoring products and related systems to customers that require measurement of ionizing radiation. Revenue is generated from product sales (e.g., detectors, meters, monitors, ...

US Nuclear Financial Statement Overview

Summary
Financial strength remains weak: the company is still structurally unprofitable with consistently negative operating results and negative operating/free cash flow. While 2025 shows improvement (higher gross margin, narrower losses, reduced cash burn, and lower debt), persistent losses plus negative shareholders’ equity (2022–2025) are major ongoing risks.
Income Statement
24
Negative
Balance Sheet
18
Very Negative
Cash Flow
22
Negative
BreakdownDec 2025Dec 2024Dec 2023Mar 2023Mar 2022
Income Statement
Total Revenue2.17M2.19M2.23M2.09M2.14M
Gross Profit1.09M1.02M924.31K788.07K1.38M
EBITDA-1.40M-1.51M-1.78M-1.49M-1.81M
Net Income-1.24M-1.74M-3.43M-2.04M-1.88M
Balance Sheet
Total Assets1.92M2.65M2.86M3.11M2.85M
Cash, Cash Equivalents and Short-Term Investments134.78K130.84K152.84K126.11K246.32K
Total Debt916.32K1.78M2.24M1.60M910.27K
Total Liabilities2.44M3.50M4.84M3.46M2.41M
Stockholders Equity-513.69K-856.16K-1.98M-348.30K441.27K
Cash Flow
Free Cash Flow-199.34K-509.05K-264.30K-1.32M-447.47K
Operating Cash Flow-199.34K-509.05K-263.44K-1.32M-441.03K
Investing Cash Flow0.00-30.77K-24.55K0.00-21.45K
Financing Cash Flow203.28K517.82K314.72K1.20M481.49K

US Nuclear Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.03
Price Trends
50DMA
0.03
Negative
100DMA
0.04
Negative
200DMA
0.06
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
48.24
Neutral
STOCH
50.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UCLE, the sentiment is Negative. The current price of 0.03 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.03, and below the 200-day MA of 0.06, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 48.24 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for UCLE.

US Nuclear Risk Analysis

US Nuclear disclosed 33 risk factors in its most recent earnings report. US Nuclear reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

US Nuclear Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
56
Neutral
$101.18M-380.000.29%26.35%-130.90%
55
Neutral
$39.45M26.003.45%-5.26%-11.19%
50
Neutral
$15.27M1.8438.45%-21.65%
47
Neutral
$77.94M839.130.15%25.56%
41
Neutral
$1.76M-1.12-0.98%33.93%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
UCLE
US Nuclear
0.03
<0.01
12.00%
LGL
LGL Group
7.60
1.27
20.08%
MIND
MIND Technology
4.36
-5.50
-55.78%
NEON
Neonode
0.90
-21.16
-95.92%
CPSH
CPS Technologies
3.86
0.41
11.88%
IMTE
Integrated Media Technology
0.47
-0.41
-46.48%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 18, 2026